EUVIMEDEUVIMED entdecken
Crossref

Unlocking Synergistic Potential: Enhancing Regorafenib Efficacy in Hepatocellular Carcinoma Through Combination Therapy With 18β-Glycyrrhetinic Acid

Jr-DI Yang, Po-Fu Yueh, Tsai Lan Liao, Ying-Tzu Chen, Fei-Ting Hsu, I-Tsang Chiang, Ching Ming Chang, Wei-Shu Wang

Anticancer Research · 2023

DOI: 10.21873/anticanres.16636 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2023. Verfasst von Jr-DI Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Urology, Department of Surgery, National Yang-Ming Chiao Tung University Hospital, Yilan, Taiwan, R.O.C. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Glycyrrhetinic Acid, Liver Neoplasms, Phenylurea Compounds. Die Arbeit wurde bisher 4-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularGlycyrrhetinic AcidLiver NeoplasmsPhenylurea CompoundsPyridinesAntineoplastic Combined Chemotherapy ProtocolsHumansAnimalsDrug SynergismMiceCell Line, TumorXenograft Model Antitumor AssaysApoptosisTOR Serine-Threonine KinasesSignal TransductionMale

Stichwörter der Autor:innen

18β-glycyrrhetinic acidHepatocellular carcinomaapoptosismTORregorafenib

Substanzen

regorafenibGlycyrrhetinic AcidPhenylurea CompoundsPyridines18alpha-glycyrrhetinic acidTOR Serine-Threonine Kinases

Autor:innen und Institutionen

  • Division of Urology, Department of Surgery, National Yang-Ming Chiao Tung University Hospital, Yilan, Taiwan, R.O.C.
  • Institute of Traditional Medicine, School of Medicine, National Yang-Ming Chiao Tung University, Taipei, Taiwan, R.O.C.
  • Department of Biological Science and Technology, China Medical University, Taichung, Taiwan, R.O.C.
  • Department of Radiation Oncology, Show Chwan Memorial Hospital, Changhua, Taiwan, R.O.C.; john740604@yahoo.com.tw.
  • Department of Radiation Oncology, Chang Bing Show Chwan Memorial Hospital, Changhua, Taiwan, R.O.C.
  • Department of Medical Imaging and Radiologic Sciences, Central Taiwan University of Science and Technology, Taichung, Taiwan, R.O.C.

Zitieren

APA

Yang, J. D., Yueh, P. F., Liao, T. L., Chen, Y. T., Hsu, F. T., Chiang, I. T., Chang, C. M., & Wang, W. S. (2023). Unlocking Synergistic Potential: Enhancing Regorafenib Efficacy in Hepatocellular Carcinoma Through Combination Therapy With 18β-Glycyrrhetinic Acid. Anticancer Research. https://doi.org/10.21873/anticanres.16636

Vancouver

Yang JD, Yueh PF, Liao TL, Chen YT, Hsu FT, Chiang IT, et al. Unlocking Synergistic Potential: Enhancing Regorafenib Efficacy in Hepatocellular Carcinoma Through Combination Therapy With 18β-Glycyrrhetinic Acid. Anticancer Research. 2023. doi:10.21873/anticanres.16636

BibTeX
@article{Yang2023,
  author = {Yang, Jr-DI and Yueh, Po-Fu and Liao, Tsai Lan and Chen, Ying-Tzu and Hsu, Fei-Ting and Chiang, I-Tsang and Chang, Ching Ming and Wang, Wei-Shu},
  title = {Unlocking Synergistic Potential: Enhancing Regorafenib Efficacy in Hepatocellular Carcinoma Through Combination Therapy With 18β-Glycyrrhetinic Acid},
  journal = {Anticancer Research},
  year = {2023},
  doi = {10.21873/anticanres.16636}
}
Kostenlos starten →